Head-to-head · Cost-Efficiency Index
Sumbare Wellness vs Ascend Medical
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Sumbare Wellness
Shoppers comfortable with a floor price that's only confirmed after a clinical review, rather than a locked-in rate.
Visit Sumbare WellnessAscend Medical
Cost-first shoppers who want georgia or Texas residents who want to bill GLP-1 treatment through insurance rather than pay cash-only compounded pricing.
Visit Ascend MedicalThe verdict
Sumbare Wellness takes it, leading the Cost-Efficiency Index 58 to 57. Sumbare Wellness is a telehealth GLP-1 and peptide-therapy provider advertising 'plans from $199/mo,' explicitly contingent on provider review rather than guaranteed at booking. Ascend Medical still earns a C — Cost-first shoppers who want georgia or Texas residents who want to bill GLP-1 treatment through insurance rather than pay cash-only compounded pricing.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Sumbare Wellness.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Sumbare Wellness | Ascend Medical |
|---|---|---|
| Cost-Efficiency Index | 58/100 | 57/100 |
| Semaglutide / mo | $199/mo (compounded) | Not disclosed |
| Tirzepatide / mo | $199/mo (compounded) | $240/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $2,388 | — |
| Tirzepatide / yr (modeled) | $2,388 | $2,880 |
| Coverage | Coverage not published | 2 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #292 | #299 |
Sumbare Wellness
58/100Where the value is
- Offers both semaglutide and tirzepatide plus a microdose program
- States clinical outcome averages (15% vs 20% body weight loss) on the pricing-adjacent page
- Claims 'no hidden fees' with pricing confirmed transparently after clinical review
The tradeoffs
- '$199/mo' is a floor, not a locked price -- actual cost is only confirmed after provider review
- No medical director or specific pharmacy partner named
Ascend Medical
57/100Where the value is
- Can bill through insurance, potentially lowering out-of-pocket cost versus cash-only compounded programs
- No-subscription, pay-per-refill model after the initial 8-week package
- Named metabolic-health chair referenced on the clinical team
The tradeoffs
- Only available to Georgia and Texas residents -- not a national service
- Unclear whether medication is compounded or brand-name; no compounding pharmacy named
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.